Moderna is under fire for not doing enough to hurt the country, especially low-income countries – and Biden’s management is being criticized for not doing enough to force Moderna’s hand.
Why it matters: Low-income countries crave more urine, and experts warn that a higher rate of globalization will increase the risk of drug overdose.
Get market news relevant to your time with Axios Markets. Write for free.
Driving news: The Biden official threatened Moderna and the government too much if it did not commit to providing adequate injections to the global COVAX program at non-profit prices, which were requested by the operators.
“Do not underestimate the role of the United States government in resolving these issues,” David Kessler, co-ordinator of the co-supervising science response team COVID-19, said at a press conference yesterday.
“I think these companies understand our strengths and understand that we will not be afraid to use them,” Kessler said. They said Moderna is capable of making about a billion dollars of additional funding in the near future.
Play mode: Moderna has been offering its own anti-doping drug to rich countries, the New York Times reported over the weekend.
Pfizer, on the other hand, has agreed to sell its vaccine at a lower price to the US government to provide low-income countries.
Controversy has been raging between Moderna and leadership for some time, but not yet over booster shots.
Yes, but: Officials speaking at the court said it was time for the federal government to leave Moderna voluntarily to take action, and to take drastic measures to increase globalization.
And they are not just workers. A group of Democratic delegates, led by Sen. Elizabeth Warren, wrote a letter to the leadership of Biden yesterday with a similar message, the Washington Post reports.
“Despite receiving large sums of money from the public from U.S. taxpayers, Moderna refused to allow the phone to share its expertise, including with the US government,” wrote lawmakers, forcing administrators to obtain more information on the federal government agreement and its rights. to the company’s data protection.
What they say: “We are committed to increasing our production and further reduction even until our vaccines are no longer needed in developing countries,” Modern CEO Stéphane Bancel recently wrote in a letter highlighting the company’s advice to increase vaccination.
Between rows: It is unclear what right the US government has to share information on the development of modern medicine with the rest of the world, which is what some politicians are doing.
Kessler said the Defense Production Act “is probably a powerful force, and this gives the president the authority to issue doses.”
But re-supplying doses does not solve the problem of the total amount of vaccines available around the world. Sharing a protective approach, on the other hand, would help other developers to design it.
Important: “We want Biden’s management to stand up, because at the end of the day … we are not living across the Pfizer and Moderna heads,” said Zain Rizvi of the Public Citizen.
Like this article? Download more from Axios and Subscribe to Axios Free Curtains.